Cardiac valve market seen reaching $24.02B by 2030

The global cardiac valve market is projected to grow from $12.41 billion in 2025 to $24.02 billion by 2030, driven by rising cardiovascular disease, more transcatheter procedures and broader adoption of minimally invasive valve technologies. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The cardiac valve market is tied directly to treatment demand for heart valve disorders and other cardiovascular diseases. - The market’s projected rise to $24.02 billion by 2030 signals continued spending on surgical, transcatheter and patient-specific valve solutions. - Rising cardiovascular deaths keep pressure on health systems to expand access to valve treatment and cardiac care.

What happened: - The Business Research Company projected the global cardiac valve market will grow from $12.41 billion in 2025 to $14.24 billion in 2026. - The company said the market will reach $24.02 billion by 2030, implying a 14.0% CAGR over the forecast period. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region through 2030. - The company released a sample report and the full market report online: Download a free sample and View the full report.

The details: - Cardiac valves are implantable devices that keep blood moving in one direction through the heart and into the major arteries. - The valves replace damaged natural valves that no longer function properly because of disease or injury. - Historical growth was linked to more valvular heart disease, expansion of cardiac surgery programs, wider use of mechanical heart valves, better surgical valve technology and improved access to cardiac care centers. - Growth through 2030 is expected to come from stronger demand for transcatheter valve interventions, more attention to cardiac care for elderly patients, hybrid cardiac procedures, higher investment in advanced valve technologies and more patient-specific valve products. - Expected market trends include more transcatheter valve procedures, a preference for bioprosthetic heart valves, greater use of minimally invasive replacements, better valve repair methods and improvements in durability and performance. - The report’s geographic coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report version includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The market outlook reflects a shift toward less invasive treatment options and more customized device design. - The emphasis on elderly care suggests demand may keep rising as populations age and valve disease becomes more common. - The CDC data cited in the release shows the broader cardiovascular burden remains large, which supports long-term demand for heart-related interventions. - In October 2024, the CDC said 919,032 people died from cardiovascular disease in 2023, equal to one in every three deaths.

What's next: - Demand is likely to keep rising as hospitals expand transcatheter programs and adopt newer valve technologies. - Market growth will likely stay strongest in regions adding cardiac care capacity and in product categories that reduce procedure invasiveness. - The Business Research Company is also promoting direct expert contact and social media channels for follow-up on the report.

The bottom line: - Cardiac valve demand is set to nearly double by 2030 as heart disease rates, aging populations and minimally invasive treatment adoption reshape the market.